Cancer cases surge in Zimbabwe

A leading Zimbabwean oncologist has raised concern over the country's rising cancer burden, warning that late diagnosis and systemic gaps continue to strain public health institutions.

Anna Mary Nyakabau, Director and Lead Oncologist at Mary Ann Oncology and founder of Cancerserve Trust Zimbabwe, said cancer cases are increasing at an alarming rate both globally and locally.

Citing global data from the World Health Organization, Nyakabau noted that approximately 20 million new cancer cases and 10 million deaths were recorded worldwide in 2022. In Zimbabwe, the Zimbabwe National Cancer Registry reports more than 8,000 new cases and over 3,000 deaths annually.

She highlighted Parirenyatwa Group of Hospitals as the country's main referral centre for cancer patients, where most cases are diagnosed at advanced stages, significantly limiting treatment options.

"Unfortunately, the majority present at an advanced stage. Myths and misconceptions contribute to the delays," she said in a recent LinkedIn post.

Zimbabwe launched its National Cancer Control Plan (2025 - 2030) last year, aimed at strengthening prevention, early detection and treatment. However, Nyakabau stressed that implementation requires urgent, coordinated action across multiple sectors.

"The unpredictable burden manifests at public hospitals, and there is need for multi-sectoral collaboration to mitigate the impact," she said.

Through Cancerserve Trust Zimbabwe, efforts are underway to bridge gaps by mobilising stakeholders to support immediate needs within the healthcare system.

Nyakabau also commended ongoing efforts by health authorities, noting that progress depends on collective action.

"The authorities are working tirelessly and together we can get further," she said.

She was recently part of a belated International Women's Day commemoration held on April 10, 2026, recognising female workers - who make up the majority of the healthcare workforce.

Nyakabau described the event as both "heartening" and an honour to attend, as Zimbabwe continues to confront a growing cancer crisis while strengthening its healthcare response.